National Comprehensive Cancer Network



About NCCN

Colon/Rectal/Anal Cancers Panel - Disclosures as of 10/19/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Tanios Bekaii-Saab, MD

None

Amgen Inc.;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

2/9/2014

Al B. Benson III, MD, FACP, FASCO

None

Agendia BV;
Bayer HealthCare;
Daiichi- Sankyo Co.;
Eli Lilly and Company;
Genentech, Inc.;
Genomic Health, Inc.;
National Cancer Institute;
Precision Therapeutics, Inc.

None

None

9/5/2013

Emily Chan, MD, PhD

None

Amgen Inc.;
Bayer HealthCare

None

None

11/27/2013

Yi-Jen Chen, MD, PhD

None

None

None

None

5/16/2013

Michael A. Choti, MD, MBA

None

Bayer HealthCare;
Bristol-Myers Squibb Company;
Genentech, Inc.;
sanofi-aventis U.S.

None

None

2/12/2013

Harry S. Cooper, MD

None

None

None

None

11/28/2013

Paul F. Engstrom, MD, FACP

None

None

None

None

2/27/2013

Peter C. Enzinger, MD

None

Boehringer Ingelheim GmbH;
Genentech, Inc.;
sanofi-aventis U.S.;
Taiho Parmaceuticals Co., Ltd.

None

None

4/4/2013

Marwan G Fakih, MD

None

None

None

None

12/15/2013

Moon Fenton, MD, PhD

None

None

None

None

1/9/2014

Deborah Freedman-Cass, PhD

None

None

None

None

3/7/2014

Charles S. Fuchs, MD, MPH

Amgen Inc.;
ImClone Systems Incorporated

Amgen Inc.;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Genomic Health, Inc.;
ImClone Systems Incorporated;
Infinity Pharmaceuticals;
Metamark Genetics;
Momenta Pharmaceuticals;
Pfizer Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

6/14/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Jean L. Grem, MD

None

Adherex Technologies Inc.

None

None

6/23/2013

Steven Hunt, MD

None

None

None

None

3/8/2013

Ahmed Kamel, MD

None

None

None

None

10/16/2012

Lucille A. Leong, MD

None

None

None

None

5/23/2013

Edward Lin, MD

Bayer HealthCare;
Bristol-Myers Squibb Company;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Schering-Plough Corporation

None

None

None

1/8/2014

Joan S. McClure, MS

None

None

None

None

8/13/2013

Mary F. Mulcahy, MD

None

None

None

None

1/26/2012

Eric Rohren, MD, PhD

None

None

None

None

5/17/2013

David P. Ryan, MD

None

Human Genome Sciences, Inc.

None

None

11/3/2011

Kilian E. Salerno, MD

None

None

None

None

10/10/2013

Leonard Saltz, MD

Amgen Inc.;
Bayer HealthCare;
Bristol-Myers Squibb Company;
CureTech Ltd.;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
OSI Pharmaceuticals, Inc.;
Astellis;
Biothera;
Immunomedex;
Pfizer Inc.;
Roche Laboratories, Inc.;
Synta Pharmaceuticals Corp.;
Taiho Parmaceuticals Co., Ltd.

Bayer HealthCare;
CureTech Ltd.;
Genentech, Inc.;
Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Taiho Parmaceuticals Co., Ltd.

None

None

9/15/2013

Sunil Sharma, MD

None

None

None

None

6/21/2011

David Shibata, MD

None

None

None

None

1/16/2014

John M. Skibber, MD

None

None

None

None

4/15/2014

William Small, MD

None

None

None

None

6/5/2012

Constantinos T. Sofocleous, MD, PhD, FSIR

National Cancer Institute;
Sirtex

Sirtex Medical Inc

None

None

6/5/2012

Alan P. Venook, MD

None

Abbott Laboratories;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation

None

None

3/12/2014

Christopher G. Willett, MD

None

None

None

None

11/14/2012